News Releases
October 1, 2026
Mayo Clinic researchers report encouraging early results from an experimental therapy targeting the genetic cause of a rare form of amyotrophic lateral sclerosis, or ALS.
September 25, 2026
September 22, 2026
September 21, 2026
September 18, 2026
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community